ISSN 1016-5169 | E-ISSN 1308-4488
pdf
The Effect of Low, Moderate, and High Doses of Rosuvastatin on Lipoprotein(A) Levels in Hyperlipidemic Patients with Impaired Fasting Glucose: A Post-Hoc Analysis [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. Ahead of Print: TKDA-37794 | DOI: 10.5543/tkda.2024.37794

The Effect of Low, Moderate, and High Doses of Rosuvastatin on Lipoprotein(A) Levels in Hyperlipidemic Patients with Impaired Fasting Glucose: A Post-Hoc Analysis

Aris P. Agouridis1, Theodosios D. Filippatos2, Christina Kostara3, Vasilis Tsimihodimos4, Michalis S. Kostapanos5
1Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece; School of Medicine, European University Cyprus, Nicosia, Cyprus; Department of Internal Medicine, German Medical Institute, Limassol, Cyprus
2Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece; Department of Internal Medicine, School of Medicine, University of Crete, Heraklion, Greece
3Laboratory of Clinical Chemistry, Faculty of Medicine, University of Ioannina, Ioannina, Greece
4Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece
5Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece; Lipid Clinic, Department of General Medicine, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom


Corresponding Author: Aris P. Agouridis
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.